Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"... Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0.0021 | 0 | 0 | 0 | CS |
| 4 | -0.03845 | -94.8212083847 | 0.04055 | 0.04055 | 0.0006 | 459 | 0.00195883 | CS |
| 12 | 0.0016 | 320 | 0.0005 | 0.0861 | 0.0005 | 1543 | 0.00365341 | CS |
| 26 | -0.0001 | -4.54545454545 | 0.0022 | 0.0861 | 0.0004 | 1688 | 0.00423342 | CS |
| 52 | -0.1479 | -98.6 | 0.15 | 0.56 | 1.0E-6 | 3860 | 0.18284515 | CS |
| 156 | -2.7479 | -99.9236363636 | 2.75 | 2.75 | 1.0E-6 | 676287 | 0.02429866 | CS |
| 260 | -0.0034 | -61.8181818182 | 0.0055 | 2.75 | 1.0E-6 | 661424 | 0.02429866 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
